Cargando…
Immune checkpoint inhibitor–induced diabetes mellitus with pembrolizumab
An 81-year-old woman with a background of metastatic melanoma on pembrolizumab with no history of diabetes was brought into the emergency department with polyuria, polydipsia and weight loss. The initial assessment was consistent with severe diabetic ketoacidosis (DKA) and prerenal acute kidney inju...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8768469/ https://www.ncbi.nlm.nih.gov/pubmed/35039353 http://dx.doi.org/10.1136/bcr-2021-245846 |